Viz.ai Honored by Goldman Sachs for Entrepreneurship
- Viz.ai granted FDA approval for AI computer-aided triage in 2018 and 2023
- Viz.ai implemented in over 1,450 hospitals covering 220 million lives
- Collaboration with 7 leading pharmaceutical and medical device companies
- None.
CEO Chris Mansi Recognized Among the Most Exceptional Entrepreneurs, 2023 Builders and Innovators
Dr. Chris Mansi was inspired by a patient who underwent a successful brain surgery and yet died because the surgery came too late. Frustrated by the unnecessary delays that had cost his patient her life, he committed to finding a better way. In 2016, Dr. Mansi joined forces with Dr. David Golan to co-found Viz.ai, establishing its mission to increase access to life-saving treatments using artificial intelligence. Under Chris’ leadership, Viz.ai was granted the first de novo approval by the FDA for AI computer-aided triage in 2018 and again in 2023 for cardiovascular machine learning-based notification software. Today, Viz.ai is implemented in over 1,450 hospitals covering 220 million lives and collaborates with 7 of the leading, global pharmaceutical and medical device companies to help detect disease earlier and direct patients to the right specialists.
“I am honored to be recognized by Goldman Sachs for entrepreneurship alongside such esteemed, visionary leaders,” said Chris Mansi. “It’s a testament to the dedication and hard work of the Viz.ai team, always putting patients first as we continue to innovate on the Viz.ai platform. I’m incredibly proud of the real-world impact that we have made by transforming healthcare and partnering with major pharmaceutical and medical device companies in service of better patient outcomes.”
“We’re delighted to recognize Chris Mansi as one of the most exceptional entrepreneurs of 2023,” said David Solomon, Chairman and CEO of Goldman Sachs. “Like everyone in this year’s class, Chris has been a visionary in their field, pushing forward innovation and redefining markets. We are excited to harness Goldman’s convening power to bring together these dynamic leaders and hear their insights.”
About Viz.ai, Inc.
Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 220 million lives across 1,450+ hospitals and health systems in the
About Goldman Sachs
Goldman Sachs is a leading global financial institution that delivers a broad range of financial services to a large and diversified client base that includes corporations, financial institutions, governments and individuals. Founded in 1869, the firm is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20231019884041/en/
Ariane Lovell
ariane.lovell@finnpartners.com
Press related questions about the Summit or Goldman Sachs, please contact Sophia Anthony at Sophia.Anthony@gs.com.
Source: Viz.ai
FAQ
Who is being recognized by Goldman Sachs?
What is Viz.ai known for?
When was Viz.ai granted FDA approval?
How many hospitals is Viz.ai implemented in?
Who does Viz.ai collaborate with?
